🇺🇸 FDA
Patent

US 7423015

Antihelminthic drugs as a treatment for hyperproliferative diseases

granted A61KA61K31/4184A61K31/4439

Quick answer

US patent 7423015 (Antihelminthic drugs as a treatment for hyperproliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
57
CPC classes
A61K, A61K31/4184, A61K31/4439, A61P, A61P1/00